Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+19.83%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$45.9B
AUM Growth
+$5.92B
(+15%)
Cap. Flow
+$208M
Cap. Flow
% of AUM
0.45%
Top 10 Holdings %
Top 10 Hldgs %
24.37%
Holding
916
New
168
Increased
229
Reduced
363
Closed
115
Top Buys
| 1 |
Tesla
TSLA
|
$465M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$329M |
| 3 |
Exxon Mobil
XOM
|
$320M |
| 4 |
GE Aerospace
GE
|
$247M |
| 5 |
Emerson Electric
EMR
|
$170M |
Top Sells
| 1 |
Royalty Pharma
RPRX
|
$365M |
| 2 |
Sensata Technologies
ST
|
$251M |
| 3 |
Fortive
FTV
|
$235M |
| 4 |
Honeywell
HON
|
$120M |
| 5 |
ITT
ITT
|
$117M |
Sector Composition
| 1 | Technology | 20.82% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Financials | 12.38% |
| 5 | Communication Services | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Cintas
CTAS
$82B
| $50.3M | 0.11% |
568,812
+215,212
| +61% | +$19M |
|
202
Cameco
CCJ
$33.1B
| $49.4M | 0.11% |
3,686,089
-800,000
| -18% | -$10.7M |
|
203
Stem
STEM
$116M
| $49M | 0.11% |
+119,662
| New | +$49M |
|
204
Moody's
MCO
$89.3B
| $48.8M | 0.11% |
168,254
-12,100
| -7% | -$3.51M |
|
|
ABMD
205
DELISTED
Abiomed Inc
ABMD
| $48.7M | 0.11% |
150,143
+49,830
| +50% | +$16.2M |
|
206
Fifth Third Bancorp
FITB
$30.2B
| $48.7M | 0.11% |
1,765,344
+583,794
| +49% | +$16.1M |
|
207
Regeneron Pharmaceuticals
REGN
$60.3B
| $48.6M | 0.11% |
100,606
-1,130
| -1% | -$546K |
|
208
Hartford Financial Services
HIG
$37B
| $48.5M | 0.11% |
989,483
-305,000
| -24% | -$14.9M |
|
209
Northrop Grumman
NOC
$82.7B
| $48.4M | 0.11% |
158,847
+11,604
| +8% | +$3.54M |
|
210
HCA Healthcare
HCA
$97.9B
| $48.3M | 0.11% |
293,900
-1,400
| -0.5% | -$230K |
|
211
XP
XP
$9.8B
| $47.9M | 0.1% |
1,206,205
-226,755
| -16% | -$9M |
|
|
TWTR
212
DELISTED
Twitter, Inc.
TWTR
| $47.7M | 0.1% |
881,600
-2,600
| -0.3% | -$141K |
|
213
Idexx Laboratories
IDXX
$51.8B
| $47.4M | 0.1% |
94,889
-309
| -0.3% | -$154K |
|
214
DexCom
DXCM
$31.3B
| $46.8M | 0.1% |
506,500
+77,824
| +18% | +$7.19M |
|
215
Ross Stores
ROST
$49.4B
| $46.8M | 0.1% |
381,020
-15,000
| -4% | -$1.84M |
|
216
Ingersoll Rand
IR
$32B
| $46M | 0.1% |
1,009,223
+657,420
| +187% | +$30M |
|
217
Devon Energy
DVN
$21.9B
| $45.8M | 0.1% |
2,899,134
+2,326,094
| +406% | +$36.8M |
|
218
Baxter International
BAX
$12.6B
| $45.7M | 0.1% |
569,002
+4,750
| +0.8% | +$381K |
|
219
Saic
SAIC
$4.91B
| $45.6M | 0.1% |
481,499
+45,511
| +10% | +$4.31M |
|
|
B
220
Barrick Mining Corporation
B
$48.3B
| $45.6M | 0.1% |
2,000,000
-200,000
| -9% | -$4.56M |
|
221
Exelon
EXC
$43.7B
| $45.4M | 0.1% |
+1,508,832
| New | +$45.4M |
|
222
American Electric Power
AEP
$57.6B
| $45.2M | 0.1% |
542,750
+293,000
| +117% | +$24.4M |
|
223
Novavax
NVAX
$1.29B
| $45M | 0.1% |
403,283
+378,283
| +1,513% | +$42.2M |
|
224
DTE Energy
DTE
$28.2B
| $44.1M | 0.1% |
426,657
+177,439
| +71% | +$18.3M |
|
225
Celldex Therapeutics
CLDX
$1.52B
| $43.8M | 0.1% |
2,500,000
+450,000
| +22% | +$7.88M |
|